A similar increasing trend was observed in the pancreas, although it did not reach statistical significance ( p > 0.05), indicating that nimotuzumab may facilitate the accumulation of NK cells in these tissues.
← all excerpts
EGFR-Targeting IgG1 Antibody Enhances NK Cell-Mediated Tumor Killing in KRAS-Mutant Pancreatic Cancer.
1
0.0500
0.0500